Clinical Trials Browser

Active not recruiting × OTHER × cabazitaxel × Clear all

NCT02703623 2026-03-06

Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT02522715 2026-02-24

Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer

Phase 1/2 Active not recruiting

37 enrolled 10 charts

Prostatic Neoplasms

NCT03263650 2026-02-17

Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

Phase 2 Active not recruiting

Prostate Cancer, Hereditary, 7, Prostatic Neoplasms

NCT04592237 2025-12-23

Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT04709276 2025-09-11

CHAMP

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT01952223 2025-07-30

PEACE2

Phase 3 Active not recruiting

Adenocarcinoma, Recurrence

NCT05340374 2025-04-06

LuCAB

Phase 1/2 Active not recruiting

Metastatic Castration-resistant Prostate Cancer

NCT02202772 2025-02-24

CGC

Phase 1/2 Active not recruiting

Carcinoma, Neoplasms, Recurrence

NCT03934840 2024-02-28

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

Phase 2 Active not recruiting

Prostatic Neoplasms